| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |